Targeting a neoantigen derived from a common TP53 mutation

Authors

Emily Hsiue

Published

March 1, 2021

Abstract

(tumor protein p53) is the most commonly mutated cancer driver gene, but drugs that target mutant tumor suppressor genes, such as

Supporters

Support the authors with ResearchCoin

Journal

Science

Topics

DOI

10.1126/science.abc8697

Targeting a neoantigen derived from a common TP53 mutation

Authors

Emily Hsiue

Published

March 1, 2021

Abstract

(tumor protein p53) is the most commonly mutated cancer driver gene, but drugs that target mutant tumor suppressor genes, such as

Supporters

Support the authors with ResearchCoin

Journal

Science

Topics

DOI

10.1126/science.abc8697

Paper

Paper

Paper

Paper

Targeting a neoantigen derived from a common TP53 mutation

Abstract

Supporters

Journal

Topics

DOI

Targeting a neoantigen derived from a common TP53 mutation

Abstract

Supporters

Journal

Topics

DOI